ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is China Shineway Pharmaceutical Group Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate 8.54% of over the last 5 years
2
Negative results in Jun 25
- ROCE(HY) Lowest at 10.85%
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.67 times
- NET SALES(Q) Lowest at HKD 1,775.25 MM
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is China Shineway Pharmaceutical Group Ltd. for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
China Shineway Pharmaceutical Group Ltd.
24.17%
0.73
25.50%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.19%
EBIT Growth (5y)
8.54%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
0.54
Tax Ratio
26.68%
Dividend Payout Ratio
48.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
48.03%
ROE (avg)
10.55%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.90
EV to EBIT
0.67
EV to EBITDA
0.57
EV to Capital Employed
0.43
EV to Sales
0.15
PEG Ratio
NA
Dividend Yield
0.02%
ROCE (Latest)
64.76%
ROE (Latest)
11.46%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 2,653.86 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -84.77 %
CASH AND EQV(HY)
Highest at HKD 7,626.23 MM
-14What is not working for the Company
ROCE(HY)
Lowest at 10.85%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.67 times
NET SALES(Q)
Lowest at HKD 1,775.25 MM
INTEREST COVERAGE RATIO(Q)
Lowest at 7,583.73
DIVIDEND PAYOUT RATIO(Y)
Lowest at 44.05%
INTEREST(Q)
Highest at HKD 6.3 MM
Here's what is working for China Shineway Pharmaceutical Group Ltd.
Operating Cash Flow
Highest at HKD 2,653.86 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Debt-Equity Ratio
Lowest at -84.77 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Cash and Eqv
Highest at HKD 7,626.23 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for China Shineway Pharmaceutical Group Ltd.
Net Sales
Lowest at HKD 1,775.25 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term sales trend is very negative
Net Sales (HKD MM)
Interest Coverage Ratio
Lowest at 7,583.73
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debtors Turnover Ratio
Lowest at 2.67 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Interest
Highest at HKD 6.3 MM
in the last five periods and Increased by 77.19% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Dividend Payout Ratio
Lowest at 44.05%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
Non Operating Income
Highest at HKD 0.53 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
